Clinical Trial Update: Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating nimotuzumab in combination with cisplatin and vinorelbine as first-line chemotherapy for recurrent or persistent cervical ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Nimotuzumab (nimotuzumab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: National Institute of Cancerología | Conditions: Cervical Cancer Recurrent or Persistent, Palliative Treatment | Phase 3 | Status: COMPLETED